33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Bergmann, L.; Donskov, F.; Motzer, R. J.; Voog, E.; Hovey, E. J.; Grüllich, C.; Nott, L. M.; Cuff, K. E.; Gil, T.; Jensen, N. V.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib (c) vs everolimus (e) in advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Grüllich, C.; Powles, T.; Motzer, R. J.; George, D. J.; Jonasch, E.; Pal, S. K.; Tannir, N. M.; Signoretti, S.; Mai, T. H.; Scheffold, C.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Investigation of HLA loss relapse after allogeneic stem cell transplantation in a global multicentric cohort (HLALOSS Consortium)
    Meeting Abstract

    Fleischhauer, K.; Toffalori, C.; Ahci, M.; Lange, V.; Lang, K.; Todaro, S.; Stempelmann, K.; Heinold, A.; Stölzel, F.; Waterhouse, M.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Long-term efficacy and cardiac, vascular and hypertension safety of bosutinib in previously treated patients with Philadelphia chromosome-positive leukemia
    Meeting Abstract

    Brümmendorf, T. H.; Gambacorti-Passerini, C.; Kim, D. W.; Mauro, M. J.; Aguiar, J.; Viqueira, A.; Leip, E.; Cortes, J. E.
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Treatment-free remission (TFR) in patients (pts) with chronic-phase chronic myeloid leukemia (CML-CP) and stable deep molecular response (DMR) discontinuing dasatinib (DASFREE)
    Meeting Abstract

    Saussele, S.; Shah, N.; García-Gutiérrez, J. V.; Jiménez-Velasco, A.; Larson, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casares, M. T.; Pane, F.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Efficacy of larotrectinib in TRK fusion cancer in adults and children
    Meeting Abstract

    Blattmann, C.; Drilon, A.; Laetsch, T. W.; Kummar, S.; DuBois, S. G.; Lassen, U. N.; Demetri, G. D.; Nathenson, M.; Doebele, R. C.; Farago, A. F.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Hypogonadism in girls after cancer therapy: Causes, diagnosis, and treatment
    Meeting Abstract

    Sklar, C.
    Hormone Research in Paediatrics (2018)

    Fulltext@MSK | Save
  • Immunotherapy for urothelial cancer: Current strategies, new directions, and biomarker approaches
    Meeting Abstract

    Rosenberg, J.
    International Journal of Urology (2018)

    Fulltext@MSK | Save
  • Quality of life in patients with advanced renal cell carcinoma in the randomized, open-label CheckMate 214 trial
    Meeting Abstract

    Grnüwald, V.; Cella, D.; Escudier, B. J.; Hammers, H. J.; George, S.; Nathan, P.; Grimm, M. O.; Rini, B. I.; Doan, J.; Ivanescu, C.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia (BFORE trial): 24-month efficacy update and results by 3-month BCR-ABL1 transcript levels
    Meeting Abstract

    Brümmendorf, T. H.; Hochhaus, A.; Isfort, S.; le Coutre, P.; Jentsch-Ullrich, K.; Schafhausen, P.; Gambacorti-Passerini, C.; Deininger, M. W.; Mauro, M. J.; Chuah, C.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save